Diabetes

  • Should metformin be used in every patient with type 2 diabetes?
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 17-20; DOI: https://doi.org/10.3949/ccjm.86a.18039

    Most patients should receive it, with exceptions. Nevertheless, it is underused.

  • A new reason to reconsider that antibiotic prescription: The microbiome
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 906-907; DOI: https://doi.org/10.3949/ccjm.85b.12018

    Prescribing an antibiotic is a far more complicated and long-lasting affair than most of us thought.

  • Acute necrotizing esophagitis
    Takeshi Kondo, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 912-913; DOI: https://doi.org/10.3949/ccjm.85a.18054

    Poorly controlled diabetes, confusion, coffee-ground emesis.

  • Our missing microbes: Short-term antibiotic courses have long-term consequences
    Martin J. Blaser, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 928-930; DOI: https://doi.org/10.3949/ccjm.85gr.18005

    Is the rise in chronic diseases due to loss of microbial diversity?

  • Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Kathryn Bux Rodeman, MD and Betul Hatipoglu, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 931-937; DOI: https://doi.org/10.3949/ccjm.85a.17088

    Chief among the challenges: millions of people have diabetes.

  • Cannabis for peripheral neuropathy: The good, the bad, and the unknown
    Vania Modesto-Lowe, MD, MPH, Rachel Bojka, MS, PA-C and Camille Alvarado, DO, MPH
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 943-949; DOI: https://doi.org/10.3949/ccjm.85a.17115

    Even where it is legal, doctors should recommend it only after careful consideration.

  • Small fibers, large impact
    Brian f. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2018, 85 (10) 731-732; DOI: https://doi.org/10.3949/ccjm.85b.10018

    The wide interest in small fi ber neuropathy may reflect our current apparent epidemic of chronic pain.

  • Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)
    Malvinder S. Parmar, MB, MS, FRCPC, FACP, FASN
    Cleveland Clinic Journal of Medicine October 2018, 85 (10) 735-736; DOI: https://doi.org/10.3949/ccjm.85c.10002

    Readers comment on hypertrophic cardiomyopathy (May 2018) and on hypoparathyroidism (March 2018).

  • In reply: Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)
    Sohab S. Radwan, MD, Khair M. Hamo, MD and Ayman A. Zayed, MD, MSc, FACE, FACP
    Cleveland Clinic Journal of Medicine October 2018, 85 (10) 736-737; DOI: https://doi.org/10.3949/ccjm.85c.10003
  • Office approach to small fiber neuropathy
    Jinny O. Tavee, MD
    Cleveland Clinic Journal of Medicine October 2018, 85 (10) 801-812; DOI: https://doi.org/10.3949/ccjm.85a.17124

    A practical approach for identifying an underlying cause is to fi rst screen for common ones.

Pages